chr2-214728859-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000465.4(BARD1):c.2151C>G(p.Ile717Met) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I717N) has been classified as Uncertain significance.
Frequency
Consequence
NM_000465.4 missense
Scores
Clinical Significance
Conservation
Publications
- breast cancerInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- familial ovarian cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000465.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BARD1 | NM_000465.4 | MANE Select | c.2151C>G | p.Ile717Met | missense | Exon 11 of 11 | NP_000456.2 | ||
| BARD1 | NM_001282543.2 | c.2094C>G | p.Ile698Met | missense | Exon 10 of 10 | NP_001269472.1 | |||
| BARD1 | NM_001282545.2 | c.798C>G | p.Ile266Met | missense | Exon 7 of 7 | NP_001269474.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BARD1 | ENST00000260947.9 | TSL:1 MANE Select | c.2151C>G | p.Ile717Met | missense | Exon 11 of 11 | ENSP00000260947.4 | ||
| BARD1 | ENST00000617164.5 | TSL:1 | c.2094C>G | p.Ile698Met | missense | Exon 10 of 10 | ENSP00000480470.1 | ||
| BARD1 | ENST00000613706.5 | TSL:1 | c.1743C>G | p.Ile581Met | missense | Exon 11 of 11 | ENSP00000484976.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
The p.I717M variant (also known as c.2151C>G), located in coding exon 11 of the BARD1 gene, results from a C to G substitution at nucleotide position 2151. The isoleucine at codon 717 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at